A study of the effects of pulsed electromagnetic field therapy with respect to serological grouping in rheumatoid arthritis.
Abstract
The positive role of pulsed electromagnetic field (PEMF) therapy in rheumatoid arthritis (RA) is known. The differential role of serological status of patients in RA is also well known. This paper presents a study of the differential effects of PEMF therapy on the two serological groups of patients. The responses of the seropositive patients are found to be more subdued. Varying effects of the therapy in alleviating the different symptomatologies indicate that the rheumatoid factor (RF) is more resistant to PEMF.
AI evidence extraction
Main findings
The study reports differential effects of PEMF therapy between serological groups in RA. Responses in seropositive patients were described as more subdued, and varying effects across symptoms suggested rheumatoid factor may be more resistant to PEMF.
Outcomes measured
- Differential response to PEMF therapy by serological status (seropositive vs seronegative)
- Symptom alleviation in RA
- Rheumatoid factor (RF) response/resistance to PEMF
Limitations
- Study design not described in abstract
- Sample size not reported
- Exposure parameters (frequency
- intensity
- duration) not reported
- Outcome measures and statistical methods not reported
View raw extracted JSON
{
"study_type": "unknown",
"exposure": {
"band": null,
"source": "pulsed electromagnetic field (PEMF) therapy",
"frequency_mhz": null,
"sar_wkg": null,
"duration": null
},
"population": "Patients with rheumatoid arthritis (RA), including seropositive and seronegative groups",
"sample_size": null,
"outcomes": [
"Differential response to PEMF therapy by serological status (seropositive vs seronegative)",
"Symptom alleviation in RA",
"Rheumatoid factor (RF) response/resistance to PEMF"
],
"main_findings": "The study reports differential effects of PEMF therapy between serological groups in RA. Responses in seropositive patients were described as more subdued, and varying effects across symptoms suggested rheumatoid factor may be more resistant to PEMF.",
"effect_direction": "mixed",
"limitations": [
"Study design not described in abstract",
"Sample size not reported",
"Exposure parameters (frequency, intensity, duration) not reported",
"Outcome measures and statistical methods not reported"
],
"evidence_strength": "insufficient",
"confidence": 0.62,
"peer_reviewed_likely": "yes",
"keywords": [
"pulsed electromagnetic field",
"PEMF",
"rheumatoid arthritis",
"seropositive",
"seronegative",
"rheumatoid factor"
],
"suggested_hubs": [
{
"slug": "clinical-therapeutic-emf",
"weight": 0.78,
"reason": "Study evaluates PEMF therapy effects in a clinical condition (rheumatoid arthritis)."
}
]
}AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.
NNEMF synthesis
Synthesis pending.